I kliniske forsøg var de hyppigst forekommende behandlingsrelaterede bivirkninger gastrointestinale forstyrrelser, særligt kvalme (43%) og opkastninger (36%).
In clinical trials, the most frequently occurring treatment-related undesirable effects were gastrointestinal disorders, specifically nausea (43%) and vomiting (36%).